Arbutus Biopharma Corp. buy Lutz69
Start price
20.09.21
/
50%
€3.79
Target price
20.09.25
-
Performance (%)
-26.16%
End price
03.04.23
€2.80
Summary
This prediction ended on 03.04.23 with a price of €2.80. The prediction for Arbutus Biopharma Corp. disappointed with a performance of -26.16%. Lutz69 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Arbutus Biopharma Corp. | 0.756% | 0.756% | 82.893% |
iShares Core DAX® | 1.937% | 1.473% | 18.596% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% |
According to Lutz69 what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Lutz69 for this prediction
In the thread Arbutus Biopharma Corp. diskutieren
Buy Arbutus Biopharma Corp.
In the thread Trading Arbutus Biopharma Corp.
Buy beendet
Stopped prediction by Lutz69 for Arbutus Biopharma Corp.
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.80
03.04.23
03.04.23
-
03.04.27
03.04.27
-12.14%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year